It was found that SIRT3 activates SOD2 and catalase to block cardiac hypertrophy in primary cardiomyocytes cultures, thereby decreasing ROS levels (Sundaresan et al., 2009). The gene discussed is SIRT3; the disease is cardiac hypertrophy.